Ultragenyx
NASDAQ: RARE
Developing innovative treatments for rare and ultra-rare diseases.
Developing innovative treatments for rare and ultra-rare diseases.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
Novato, CAInitial Investment
2011Ultragenyx (NASDAQ: RARE) a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases.
“F-Prime was a great partner, they understood the vision we had at Ultragenyx, and helped us make it a reality.”
Emil Kakkis, M.D., Ph.D., CEO
